
AFYIA Diagnostics makes reliable, easy-to-use molecular diagnostic kits for MPOX. They combine artificial intelligence, molecular biology, and a rigorous industrial process to ensure accuracy. The core technology includes kit development, AI-driven design, and scalable manufacturing for clinical labs. The product targets the B2B diagnostics market, including hospitals, clinics, and diagnostic laboratories. The company aims to expand access by reducing cost and shipping constraints.

AFYIA Diagnostics makes reliable, easy-to-use molecular diagnostic kits for MPOX. They combine artificial intelligence, molecular biology, and a rigorous industrial process to ensure accuracy. The core technology includes kit development, AI-driven design, and scalable manufacturing for clinical labs. The product targets the B2B diagnostics market, including hospitals, clinics, and diagnostic laboratories. The company aims to expand access by reducing cost and shipping constraints.